Drug Type Small molecule drug |
Synonyms AZD 8529 |
Target |
Action modulators |
Mechanism mGluR2 modulators(Metabotropic glutamate receptor 2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC35H37F3N4O2 |
InChIKeyMPVPIQIAGJORKK-UHFFFAOYSA-N |
CAS Registry877145-53-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Phase 2 | United States | 01 Jun 2009 | |
Tobacco Use Disorder | Phase 2 | - | - | |
Memory Disorders | Phase 1 | United States | 01 Feb 2010 |
Phase 2 | 214 | (AZD8529 Low Dose) | szliyqsqwc = jrtxhblghg ajpvsvnlph (mggvncwjdi, zskxbkwizc - vmjwnfadjc) View more | - | 29 Nov 2017 | ||
(AZD8529 High Dose) | szliyqsqwc = uprddrymhs ajpvsvnlph (mggvncwjdi, iqjrkkdnvs - qzxcuezdqt) View more |